Effect of antihypertensive treatment and N(ω)-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats

Journal of Hypertension

Volumn 14, Issue 11, 1996, Pages 1331-1339

  Li, Jin S ^a   Sventek, Pavol ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin converting enzyme inhibitor; Aorta; Calcium channel antagonist; Endothelin 1; Endothelium derived relaxing factor; Hypertension; Hypertrophy; Mesenteric arteries; Messenger RNA; N( ) nitro L arginine methyl ester; Nitric oxide synthase; Small arteries

Indexed keywords

ARGININE METHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CILAZAPRIL; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; MESSENGER RNA; MIBEFRADIL; NITRIC OXIDE SYNTHASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; AORTA; ARTERIOLE; ARTICLE; BLOOD PRESSURE; CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HEART HYPERTROPHY; HYPERTENSION; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; NORTHERN BLOTTING; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029862767     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199611000-00012     Document Type: Article

References (35)

1. Deng LY, Schiffrin EL: Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol 1992, 262:H1782-H1787.
2. Larivière R, Thibault G, Schiffrin EL: Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993, 21: 294-300.
3. Li JS, Larivière R, Schiffrin EL: Effect of a non selective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension 1994, 24:183-188.
4. Schiffrin EL: Endothelin, potential role in hypertension and vascular hypertrophy. Brief review. Hypertension 1995, 25:1135-1143.
5. Schiffrin EL, Larivière R, Li J-S, Sventek P, Touyz RM: Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995, 25:769-773.
6. Li JS, Schürch W, Schiffrin EL: Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Am J Hypertens 1996, 9:803-811.
7. Schiffrin EL, Larivière R, Li J-S, Sventek P: Enhanced expression of endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996, 33:235-248.
8. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
9. Deng LY, Schiffrin EL: Calcium dependence of effects of endothelin on rat mesenteric microvessels. Can J Physiol Pharmacol 1991, 69: 798-804.
10. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992, 19:131-137.
11. Sventek P, Li J-S, Grove K, Deschepper CF, Schiffrin EL: Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996, 27:49-55.
12. Li J-S, Deng LY, Grove K, Deschepper CF, Schiffrin EL: Comparison of endothelin antagonism and angiotensin converting enzyme inhibition on blood pressure and vascular structure in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996, 28:188-195.
13. Arnal JF, El Amrani A-I, Chatellier G, Ménard J, Michel J-B: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993, 22:380-387.
14. Deng LY, Thibault G, Schiffrin EL: Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens 1993, 15:527-537.
15. Li J-S, Schiffrin EL: Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens 1994, 7:996-1004.
16. Dunn WR, Gardiner SM: No evidence of vascular remodeling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens 1995,13:849-857.
17. Schiffrin EL: Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension [editorial]. J Hypertens 1995,13:817-821.
18. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83: 1774-1777.
19. Li J-S, Schiffrin EL: Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996, 28:68-74.
20. Ormsbee HS, Ryan CF: Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J Pharmacol Sci 1973, 62:255-257.
21. Li J-S, Schiffrin EL: Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995, 25:495-500.
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
23. Sakurai T, Yanagisawa M, Inoue A, Ryan US, Kiura S, Mitsui Y, et al.: cDNA cloning, sequencing analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun 1991, 175: 44-47.
24. Torczynski R, Bollon AP, Fuke M: The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res 1983, 11:4879-4890.
25. Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991, 4:303-308.
26. Day R, Larivière R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995, 8:294-300.
27. Schiffers PMH, Fazzi GE, Van Ingen Schenau D, De Mey JGR: Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler Thromb 1994, 14:420-426.
28. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T: Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension 1995, 25:449-452.
29. Li J-S, Schiffrin EL: Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries in SHR. Am J Hypertens 1996, in press.
30. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993, 72:387-395
31. Ashkenazi A, Ramachandran J, Capon DJ: Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature 1989, 340:146-150
32. Pinkas-Kramarski R, Stein R, Lindenboim L, Sokolovsky M: Growth factor-like effects mediated by muscarinic receptors in PC12M1 cells. J Neurochem 1992, 59:2158-2166.
33. Mazza E, Ghigo E, Boffano G, Valetto M, Maccario M, Arvat E, et al.: Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. Eur J Pharmacol 1994, 254:17-20.
34. Griffin SA, Brown WCB, Macpherson F, McGrath JC, Wilson VG, Korsgaard N, et al.: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991, 17:626-635.
35. Jover B, Herizi A, Ventre F, Dupon M, Mimran A: Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993, 21:944-948.